What is the main business of Evalab?

The main business activity of Evalab focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 16, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Marszałkowska 58, 00-545 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2019 to December 31, 2019.

What was the revenue?

In 2019, the company's revenue reached $136,632.

No, the company recorded a net loss of $8,073 in 2019.

What is the main operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $92,103 in 2019, representing 68% of all operating expenses.

Evalabsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-11-16

Share capital

5,000.00 PLN

Registered address

ul. Marszałkowska 58/15, 00-545 Warszawa, Poland

Financials

Filing timeliness

No financial statement for 2020 – the filing deadline has passed.

2020not filed
201929/09/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2019.

Results vs industry

Revenue

This companyUSD 136.63kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -8.07kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 134.47kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 36.03kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Tomasz Buzuk – President of the Management Board

Tadeusz Niedziałkowski – Attorney-in-fact (sole)

Manner of representation

The President of the Management Board and each member of the management board are authorized to submit declarations of will on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Ewa Wiśniewskaage 48	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2019-01-25 to 2024-01-10.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

4 closed proceedings recorded in KRZ history.

Registration date	Proceeding type	Status
Mar 22, 2025	Discontinued enforcement proceedings	Closed
Apr 17, 25	Discontinued enforcement proceedings	Closed
Apr 17, 25	Discontinued enforcement proceedings	Closed
Apr 17, 25	Discontinued enforcement proceedings	Closed

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Aimedicalsp. z o.o.	$240,059.72	aimedical.pl
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl